China Medical GatewayLoading your healthcare gateway…

The First Affiliated Hospital of Sun Yat-sen University (Zhongshan First Hospital)

The First Affiliated Hospital of Sun Yat-sen University (Zhongshan First Hospital) — Guangzhou

Hospital Profile

2. Medical Milestones 3. Core Competencies and Patient Care 4. Advanced Technology and Infrastructure 5. International Patient Service Support (such as special departments for hosting international friends and services of the International Department) Sun Yat-sen University Affiliated Hospital (Sun Yat-sen First Hospital) was established in 1910. It has the Yuexiu Main Hospital, Huangpu Branch, and Nansha Branch, and co-establishes national regional medical centers with Guangxi and Guizhou. It serves as a guiding unit for the establishment of comprehensive national medical centers and a pilot hospital for high-quality development of national public hospitals, having been rated A for six consecutive years in the national tertiary public hospital performance monitoring. It possesses 5 national key disciplines and 36 national clinical key specialties. It gathers eight national first-level professors, including Liang Boqiang and Xie Zhiguang, and 61 national high-level talents. It became the first medical institution internationally to receive the AMEE ASPIRE-to-Excellence award from the European Medical Education Alliance, and the first "AMEE Excellent Regional Center" is located here.

Medical Milestones

Founded in 1910; performed the country's first toe replantation surgery in 1965; independently developed the country's first extracorporeal counterpulsation device in 1973; successfully carried out the country's first kidney transplant, the world's 8th/China's 1st separation of conjoined twins, the country's first second/third-generation IVF baby, the nation's first craniopagus twins separation, Asia's first combined liver-kidney transplant and multi-organ transplants; in 2017, successfully performed the world's first 'ischemia-free' organ transplant technology (awarded the Grand Prize at the 2020 International Quality Innovation Competition); in 2021, performed the world's first 'ischemia-free' heart transplant, and in 2023, this technology was included in the World Organ Transplant Guidelines.

Key Capabilities & Patient Care

As a center for the diagnosis and treatment of complex and severe diseases in South China, it led the formulation of China's first critical care medicine guidelines and the "ICU Diagnosis and Treatment Guidelines and Management Standards," reducing the mortality rate of severe infections to 26%. It also leads the National Critical Care Medicine Specialist Alliance (250 institutions), the National IBD Alliance (480 institutions, covering over 76% of patients), and the Peritoneal Dialysis Specialist Alliance (1,951 primary hospitals, awarded the 2022 International Quality Innovation Contest Innovation Award). It has long-term support programs for Nyingchi and Baimaxu in Tibet, Kashgar in Xinjiang, Sanming in Fujian, and multiple locations in Guangdong, and has dispatched medical teams to Ghana, Equatorial Guinea, Fiji, and Dominica to provide assistance.

Advanced Technology

Equipped with Da Vinci surgical robots, bronchoscopy diagnostic and treatment robots, orthopedic robots, neurosurgical robots, PET-MR, PET-CT, multi-core imaging 3.0T MRI, advanced dual-source CT, medical linear accelerators, and various hybrid operating rooms; relies on the 'Hong Kong-Macau Medical Devices Access' program to introduce cutting-edge equipment; has intensive care units, an external counter-pulsation treatment center, a blood purification center, and a peritoneal dialysis center (top three in the world, first in the Asia-Pacific region). Established 30 provincial and ministerial-level or above platforms including the National-Local Joint Engineering Laboratory for Vascular Disease Diagnosis and Treatment Technology; independently developed decellularized neural transplantation material 'Shenqiao'. Statistics: • Bed capacity: approximately 4,300 beds (2024) • Total staff: approximately 10,000 employees (2024) • Inpatients: 171,200 discharges (2024) • Outpatient and emergency visits: 4.186 million (2024) • Inpatient and elective surgeries: 76,405 national examination surgeries (2024) • Number of senior title physicians: official total not disclosed; estimated about 1,200–1,600 people (this is an estimate, not official data, calculated based on 10,000 employees × 12%-16%)

International Patient Services

Cooperates with more than 40 top universities and medical institutions worldwide. Collaborates with Massachusetts General Hospital (MGH) and Dana-Farber Cancer Institute (DFCI) in the United States on discipline development, talent training, and telemedicine; jointly established China's first international robotic surgery training center with the University of California, Berkeley (to train talent domestically and in the Asia-Pacific region); co-built an international clinical research center with the University of Birmingham in the UK, and an AI clinical research center with Nanyang Technological University in Singapore; has trained 313 medical undergraduates from international regions and Hong Kong and Macau.

Return to Home